Results 131 to 140 of about 1,887,325 (181)

Comparison of serum ischemia modified albumin levels between preeclamptic and healthy pregnant women. [PDF]

open access: yesRev Bras Ginecol Obstet
Zuhal D   +6 more
europepmc   +1 more source

Ischemia-Modified Albumin (IMA) Is Associated with Poor Survival in Patients with Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF): A Pilot Study. [PDF]

open access: yesAntioxidants (Basel)
Zinellu A   +12 more
europepmc   +1 more source

Ischemia-Modified Albumin in Gynecology

open access: yesBiomarkers in Medicine, 2021
Background: Ischemia-modified albumin (IMA) is an oxidative stress marker used to assess the presence and severity of oxidative stress. This marker was first used for early diagnosis of myocardial ischemia. Materials & methods: A variety of IMA studies were carried out to show the effect of oxidative stress on gynecological disorders.
Mehmet F Kıncı   +2 more
core   +4 more sources

Ischemia modified albumin in pregnancy

open access: yesEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
In normal pregnancies, a hypoxic intrauterine environment seems necessary for early trophoblast development. In this context, maternal serum levels of ischemia-modified albumin (IMA) are elevated, reflecting the oxidative stress associated with placental development.
ROSSI, Alberto   +5 more
core   +10 more sources
Some of the next articles are maybe not open access.

Related searches:

Ischemia modified albumin in perinatology

European Journal of Obstetrics, Gynecology and Reproductive Biology, 2017
Ischemia modified albumin is a novel marker of ischemia generated due to hypooxygenation and increased hydroxyl free radicals in low pH. The molecule has been licenced for clinical use as an early marker for acute coronary syndrome in cardiology. Since presence of ischemia might have serious and sometimes devastating effects in perinatology, various ...
Aslı Yarcı Gürsoy   +1 more
exaly   +3 more sources

Ischemia-Modified Albumin Predicts Mortality in ESRD

open access: yesAmerican Journal of Kidney Diseases, 2006
The primary study aim is to determine whether ischemia-modified albumin (IMA) levels predict mortality in patients with end-stage renal disease (ESRD). The secondary aim is to determine characteristics of patients with elevated IMA levels.A prospective observational study of 114 renal transplantation candidates was performed.
Rajan, Sharma   +7 more
openaire   +3 more sources

Standardization of ischemia-modified albumin testing: adjustment for serum albumin

Clinical Chemistry and Laboratory Medicine, 2007
The diagnostic approach to acute myocardial infarction (AMI) is still one of the most challenging and controversial medical issues. Although the measurement of cardiospecific troponins has emerged as the gold standard for management of patients with acute chest pain, it is often unsuitable for early diagnosis, as nearly 50% of patients may present with
Martina Montagnana   +2 more
exaly   +5 more sources

Home - About - Disclaimer - Privacy